美敦力召回批号A62881的Grafton DBM异体骨产品
Grafton" DBM and Grafton Plus" DBM contain demineralized human bone tissue combined with an inert additive to yield a demineralized bone matrix (DBM) allograft product having a particular physical form and/or handling property. Grafton DBM Gel and Grafton Plus DBM Paste are produced from a powder form of DBM, while Grafton DBM Flex, Putty, Matrix, Crunch" and Orthoblend are produced from a fiber form of DBM Crunch" also contains demineralized bone chips/cubes, while Grafton DBM Orthoblend contains non-demineralized cancellous bone chips in addition to DBM. Grafton DBM and Grafton Plus DBM are malleable and can be molded or cut into various sizes and shapes according to the intended implant site.
美敦力在供体记录复核中发现批号A62881的供体未满足与微生物相关的全部供体合格要求,正在召回该供体组织生产的未使用产品。该供体骨组织检出丁酸梭菌,虽经伽马辐照且成品无菌检测合格,植入后仍存在梭菌感染可能。涉及产品包括Grafton DBM与Grafton Plus DBM系列异体脱钙骨基质。
召回原因指向供体组织微生物筛查缺口,读者可据此了解异体骨基质产品的供体筛查风险点。
来源:openFDA 器械召回 · api.fda.gov